Literature DB >> 21684347

Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals.

Edmond J Byrnes1, Karen H Bartlett, John R Perfect, Joseph Heitman.   

Abstract

Infectious fungi are among a broad group of microbial pathogens that has and continues to emerge concomitantly due to the global AIDS pandemic as well as an overall increase of patients with compromised immune systems. In addition, many pathogens have been emerging and re-emerging, causing disease in both individuals who have an identifiable immune defect and those who do not. The fungal pathogen Cryptococcus gattii can infect individuals with and without an identifiable immune defect, with a broad geographic range including both endemic areas and emerging outbreak regions. Infections in patients and animals can be severe and often fatal if untreated. We review the molecular epidemiology, population structure, clinical manifestations, and ecological niche of this emerging pathogen.
Copyright © 2011 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21684347      PMCID: PMC3318971          DOI: 10.1016/j.micinf.2011.05.009

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  122 in total

1.  The mating type-specific homeodomain genes SXI1 alpha and SXI2a coordinately control uniparental mitochondrial inheritance in Cryptococcus neoformans.

Authors:  Zhun Yan; Christina M Hull; Sheng Sun; Joseph Heitman; Jianping Xu
Journal:  Curr Genet       Date:  2007-03       Impact factor: 3.886

2.  Feline pyothorax: a retrospective study of 27 cases in Australia.

Authors:  Vanessa R Barrs; Graeme S Allan; Patricia Martin; Julia A Beatty; Richard Malik
Journal:  J Feline Med Surg       Date:  2005-04-20       Impact factor: 2.015

3.  Evaluation of risk factors for Cryptococcus gattii infection in dogs and cats.

Authors:  Colleen G Duncan; Craig Stephen; John Campbell
Journal:  J Am Vet Med Assoc       Date:  2006-02-01       Impact factor: 1.936

4.  Cryptococcosis in ferrets: a diverse spectrum of clinical disease.

Authors:  R Malik; B Alderton; D Finlaison; M B Krockenberger; H Karaoglu; W Meyer; P Martin; M P France; J McGill; S J Lester; C R O'Brien; D N Love
Journal:  Aust Vet J       Date:  2002-12       Impact factor: 1.281

Review 5.  Spread of Cryptococcus gattii into Pacific Northwest region of the United States.

Authors:  Kausik Datta; Karen H Bartlett; Rebecca Baer; Edmond Byrnes; Eleni Galanis; Joseph Heitman; Linda Hoang; Mira J Leslie; Laura MacDougall; Shelley S Magill; Muhammad G Morshed; Kieren A Marr
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

6.  Iridovirus and microsporidian linked to honey bee colony decline.

Authors:  Jerry J Bromenshenk; Colin B Henderson; Charles H Wick; Michael F Stanford; Alan W Zulich; Rabih E Jabbour; Samir V Deshpande; Patrick E McCubbin; Robert A Seccomb; Phillip M Welch; Trevor Williams; David R Firth; Evan Skowronski; Margaret M Lehmann; Shan L Bilimoria; Joanna Gress; Kevin W Wanner; Robert A Cramer
Journal:  PLoS One       Date:  2010-10-06       Impact factor: 3.240

7.  The trehalose synthesis pathway is an integral part of the virulence composite for Cryptococcus gattii.

Authors:  Popchai Ngamskulrungroj; Uwe Himmelreich; Julia A Breger; Christabel Wilson; Methee Chayakulkeeree; Mark B Krockenberger; Richard Malik; Heide-Marie Daniel; Dena Toffaletti; Julianne T Djordjevic; Eleftherios Mylonakis; Wieland Meyer; John R Perfect
Journal:  Infect Immun       Date:  2009-08-03       Impact factor: 3.441

8.  Communicating the risks of a new, emerging pathogen: the case of Cryptococcus gattii.

Authors:  Anne-Marie Nicol; Christie Hurrell; Will McDowall; Karen Bartlett; Negar Elmieh
Journal:  Risk Anal       Date:  2008-04       Impact factor: 4.000

9.  Cryptococcosis in domestic animals in Western Australia: a retrospective study from 1995-2006.

Authors:  S McGill; R Malik; N Saul; S Beetson; C Secombe; I Robertson; P Irwin
Journal:  Med Mycol       Date:  2009       Impact factor: 4.076

Review 10.  The challenge of emerging and re-emerging infectious diseases.

Authors:  David M Morens; Gregory K Folkers; Anthony S Fauci
Journal:  Nature       Date:  2004-07-08       Impact factor: 49.962

View more
  62 in total

Review 1.  Adaptation of Cryptococcus neoformans to mammalian hosts: integrated regulation of metabolism and virulence.

Authors:  Jim Kronstad; Sanjay Saikia; Erik David Nielson; Matthias Kretschmer; Wonhee Jung; Guanggan Hu; Jennifer M H Geddes; Emma J Griffiths; Jaehyuk Choi; Brigitte Cadieux; Mélissa Caza; Rodgoun Attarian
Journal:  Eukaryot Cell       Date:  2011-12-02

Review 2.  Ten challenges on Cryptococcus and cryptococcosis.

Authors:  Maurizio Del Poeta; Arturo Casadevall
Journal:  Mycopathologia       Date:  2011-09-24       Impact factor: 2.574

3.  Multicenter study evaluating the Vitek MS system for identification of medically important yeasts.

Authors:  Lars F Westblade; Rebecca Jennemann; John A Branda; Maureen Bythrow; Mary Jane Ferraro; Omai B Garner; Christine C Ginocchio; Michael A Lewinski; Ryhana Manji; A Brian Mochon; Gary W Procop; Sandra S Richter; Jenna A Rychert; Linda Sercia; Carey-Ann D Burnham
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

4.  Contribution of Laccase Expression to Immune Response against Cryptococcus gattii Infection.

Authors:  Adithap Hansakon; Popchai Ngamskulrungroj; Pornpimon Angkasekwinai
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

5.  The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme.

Authors:  Andrew G S Warrilow; Josie E Parker; Claire L Price; W David Nes; Edward P Garvey; William J Hoekstra; Robert J Schotzinger; Diane E Kelly; Steven L Kelly
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

6.  Susceptibility of intact germinating Arabidopsis thaliana to human fungal pathogens Cryptococcus neoformans and C. gattii.

Authors:  Katherine M Warpeha; Yoon-Dong Park; Peter R Williamson
Journal:  Appl Environ Microbiol       Date:  2013-02-22       Impact factor: 4.792

7.  Fungal infections of the central nervous system.

Authors:  Claire S Jacobs; Mark R Etherton; Jennifer L Lyons
Journal:  Curr Infect Dis Rep       Date:  2014-12       Impact factor: 3.725

8.  Isavuconazole activity against Aspergillus lentulus, Neosartorya udagawae, and Cryptococcus gattii, emerging fungal pathogens with reduced azole susceptibility.

Authors:  K Datta; P Rhee; E Byrnes; G Garcia-Effron; D S Perlin; J F Staab; K A Marr
Journal:  J Clin Microbiol       Date:  2013-06-26       Impact factor: 5.948

Review 9.  The unfolded protein response (UPR) pathway in Cryptococcus.

Authors:  Seon Ah Cheon; Kwang-Woo Jung; Yong-Sun Bahn; Hyun Ah Kang
Journal:  Virulence       Date:  2013-10-18       Impact factor: 5.882

Review 10.  Calcineurin in fungal virulence and drug resistance: Prospects for harnessing targeted inhibition of calcineurin for an antifungal therapeutic approach.

Authors:  Praveen R Juvvadi; Soo Chan Lee; Joseph Heitman; William J Steinbach
Journal:  Virulence       Date:  2016-06-20       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.